This project is no longer listed in the FindAPhD
database and may not be available.
This project is a self-funded project so you will to obtain your own funding. Although it states 'Applications accepted all year round' we do encourage that the course commences either in January, April, July or September
To apply you need to choose: Faculty of Biomedical Sciences under the ’Faculty’ section, School of Physiology and Pharmacolgy (PhD) under the ’programme choice’ section. Additionally under the ’Research Details’ section, please indicate that you are applying for a self funded project and give the project title and names of supervisors.
Abdulqawi R, Dockry R, Holt K, Layton G, McCarthy BG, Ford AP, Smith JA. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet. 2015 385, 1198-205.
Ford AP, Undem BJ, Birder LA, Grundy D, Pijacka W, Paton JF. P2X3 receptors and sensitization of autonomic reflexes. Auton Neurosci. 2015; 191, 16-24.
McBryde FD, Abdala AP, Hendy EB, Pijacka W, Marvar P, Moraes DJ, Sobotka PA, PatonJF. The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nat Commun. 2013; 4, 2395. doi: 10.1038/ncomms3395.
Niewiński P, Janczak D, Rucinski A, Jazwiec P, Sobotka PA, Engelman ZJ, Fudim M, Tubek S, Jankowska EA, Banasiak W, Hart EC, Paton JF, Ponikowski P. Carotid body removal for treatment of chronic systolic heart failure. Int J Cardiol. 2013;168, 2506-9.
Paton JF, Sobotka PA, Fudim M, Engelman ZJ, Hart EC, McBryde FD, Abdala AP, Marina N, Gourine AV, Lobo M, Patel N, Burchell A, Ratcliffe L, Nightingale A. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension, 2013; 61, 5-13.
FTE Category A staff submitted: 64.60
Research output data provided by the Research Excellence Framework (REF)Click here to see the results for all UK universities